Table 1

Characteristics of patients with new-onset diabetes

201820192020P value
Age, years (mean ± SD)13.5 ± 2.414.2 ± 2.514.0 ± 2.60.3462
HbA1c, % (IQR)10.3 (5.0)8.3 (5.4)10.4 (4.1)0.0267
HbA1c, mmol/mol (IQR)89 (31)67 (36)90 (21)
%BMIp95128 ± 31129 ± 28135 ± 310.2765
Ethnicity, n (%)0.0065
 Latinx36 (82)44 (67)45 (55)
 Non-Latinx7 (16)7 (11)13 (16)
 Unknown1 (2)15 (22)24 (29)
Race, n (%)NA
 White7 (16)16 (24)15 (18)
 Black3 (7)3 (5)7 (9)
 Asian2 (5)2 (3)2 (2)
 Native American/Eskimo0 (0)0 (0)1 (1)
 Other31 (70)35 (53)47 (57)
 Unknown1 (2)10 (15)10 (12)
New-onset patients, n (% female)44 (57)66 (55)82 (46)NA
DKA, n (%)4 (9)2 (3)16 (20)0.0290
Severe DKA (DKA/new), n (%)0/44 (0)0/66 (0)2/82 (2)NA
Pancreatic antibody, n (%)NA
 Positive2 (5)2(3)1 (1)
 Negative35 (80)61(92)74 (90)
 Not done7 (16)3(5)7 (9)
SARS-CoV2 prevalence in DKANA
 SARS-CoV2 PCR+, n (%)0/14 (0)
 SARS-CoV2 IgG, n (%)2/6 (33)
  • Bold P values are statistically significant (P < 0.05). %BMIp95, excess percent of the 95th percentile. NA, not applicable.

  • No information was available on whether one patient was in DKA at diagnosis.

  • Only subjects admitted as inpatients to CHLA for DKA were tested.